Skip to content

a study of Agnimantha both species to find efficacy in increasing blood hemoglobin level.

A COMPARATIVE PHARMACO-CLINICAL STUDY OF AGNIMANTHA (PREMNA INTEGRIFOLIA LINN & CLERODENDRUM PHLOMIDIS LINN.) IN PANDU ROGA W.S.R. TO IRON DEFICIENCY ANEMIA. - NIL

Status
Unknown
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/076068
Enrollment
30
Registered
2024-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Pt. Khusi Lal Sharma Government Ayurveda College and Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals aged between 15 to 55 years without any discrimination of gender, caste, religion, etc. 2. Patients fulfilling the diagnostic criteria. 3. Individuals having clinical Sign and symptoms of Pandu according to Ayurvedic classics. 4. Individuals who will give written consent for the study. 5. Hb% between 8 gm to 11gm.

Exclusion criteria

Exclusion criteria: 1. Individuals having any known systemic disorders like Cardiac disorders, Renal and Hepatic impairment, Diabetes Mellitus, Thyroid disorders, Gynecological diseases, and any type of Cancers. 2. Pregnancy and Lactating mothers. 3. Others type of known anemia like hemolytic, megaloblastic, pernicious, sickle cell and all types of secondary congenital hereditary and genetically acquired anemia will be excluded. 4. Hb level less than 8 gm/dl. 5. Individuals below 15 years and above 55 years. 6. Any continuing blood loss e.g., Hematemesis, Melena, bleeding piles, etc.

Design outcomes

Primary

MeasureTime frame
Relief in Pandu Roga Subjective parameters 1.Panduta (Pallor of the body) 2.Anna-Aruchi (Loss of appetite) 3.Pindikoudvesthan (Cramp in calf region). 4.Akchikutshotha (Periorbitledema) 5. Dourbalya (Weakness) 6. Ayasena Shwasa (exertional dyspnoea) 7.Hriday Spandana (Palpitation) Timepoint: subjective parameters will be compared after 30-days intervals.

Secondary

MeasureTime frame
Change in Mean Haemoglobin level and Relief in objective parameters Like CBC, ESRTimepoint: objective parameters like CBC and ESR will be compared after 30-day intervals.

Countries

India

Contacts

Public ContactDrTej singh Jatav

Pt.Khusi Lal Sharma Government Autonomous Ayurveda College and Institute

sharmavinod389@gmail.com9926379195

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026